US 10258627
DNA-PK inhibitors
granted A61KA61K31/506A61K31/5377
Quick answer
US patent 10258627 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/506, A61K31/5377, A61K31/5386, A61P